Search Results

There are 8445 results for: content related to: Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection

  1. You have free access to this content
    The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

    Hepatology

    Volume 59, Issue 1, January 2014, Pages: 109–120, Jason Grebely, Kimberly Page, Rachel Sacks-Davis, Maarten Schim van der Loeff, Thomas M. Rice, Julie Bruneau, Meghan D. Morris, Behzad Hajarizadeh, Janaki Amin, Andrea L. Cox, Arthur Y. Kim, Barbara H. McGovern, Janke Schinkel, Jacob George, Naglaa H. Shoukry, Georg M. Lauer, Lisa Maher, Andrew R. Lloyd, Margaret Hellard, Gregory J. Dore, Maria Prins and on behalf of the InC3 Study Group

    Version of Record online : 22 NOV 2013, DOI: 10.1002/hep.26639

  2. You have free access to this content
    Role of IL28B for chronic hepatitis C treatment toward personalized medicine

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 241–249, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Version of Record online : 27 JAN 2014, DOI: 10.1111/jgh.12475

  3. You have free access to this content
    Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution

    Hepatology

    Volume 55, Issue 6, June 2012, Pages: 1684–1691, Lin Liu, Brian E. Fisher, David L. Thomas, Andrea L. Cox and Stuart C. Ray

    Version of Record online : 18 APR 2012, DOI: 10.1002/hep.25575

  4. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  5. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106

  6. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  7. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection

    Journal of Viral Hepatitis

    Volume 19, Issue 3, March 2012, Pages: 173–181, H.-Y. Rao, D.-G. Sun, D. Jiang, R.-F. Yang, F. Guo, J.-H. Wang, F. Liu, H.-Y. Zhang, H.-H. Zhang, S.-C. Du, Q. Jin, H. Qin, A.-S.-F. Lok and L. Wei

    Version of Record online : 4 AUG 2011, DOI: 10.1111/j.1365-2893.2011.01497.x

  8. You have free access to this content
    Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection

    Hepatology

    Volume 52, Issue 4, October 2010, Pages: 1216–1224, Jason Grebely, Kathy Petoumenos, Margaret Hellard, Gail V. Matthews, Vijayaprakash Suppiah, Tanya Applegate, Barbara Yeung, Phillipa Marks, William Rawlinson, Andrew R. Lloyd, David Booth, John M. Kaldor, Jacob George and Gregory J. Dore

    Version of Record online : 29 JUL 2010, DOI: 10.1002/hep.23850

  9. You have free access to this content
    Poster Sessions

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 92A–207A,

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26726

  10. Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1208–1216, Kentaro Matsuura, Tsunamasa Watanabe, Sayuki Iijima, Shuko Murakami, Kei Fujiwara, Etsuro Orito, Etsuko Iio, Mio Endo, Atsunori Kusakabe, Noboru Shinkai, Tomokatsu Miyaki, Shunsuke Nojiri, Takashi Joh and Yasuhito Tanaka

    Version of Record online : 17 FEB 2014, DOI: 10.1111/hepr.12294

  11. You have free access to this content
    Host genomics and HCV treatment response

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 2, February 2012, Pages: 212–222, Paul J Clark and Alexander J Thompson

    Version of Record online : 20 JAN 2012, DOI: 10.1111/j.1440-1746.2011.06918.x

  12. You have free access to this content
    HCV: Pathogenesis

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1168A–1190A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26881

  13. Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort

    Journal of Viral Hepatitis

    Volume 22, Issue 12, December 2015, Pages: 1020–1032, J. S. Doyle, K. Deterding, J. Grebely, H. Wedemeyer, R. Sacks-Davis, T. Spelman, G. Matthews, T. M. Rice, M. D. Morris, B. H. McGovern, A. Y. Kim, J. Bruneau, A. R. Lloyd, K. Page, M. P. Manns, M. E. Hellard, G. J. Dore and on behalf of the InC3 Study Group

    Version of Record online : 22 JUN 2015, DOI: 10.1111/jvh.12429

  14. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  15. You have free access to this content
    IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2060–2070, Heiyoung Park, Elisavet Serti, Onyinyechi Eke, Brian Muchmore, Ludmila Prokunina-Olsson, Stefania Capone, Antonella Folgori and Barbara Rehermann

    Version of Record online : 19 NOV 2012, DOI: 10.1002/hep.25897

  16. Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study

    Journal of Viral Hepatitis

    Volume 22, Issue 9, September 2015, Pages: 708–717, B. Hajarizadeh, B. Grady, K. Page, A. Y. Kim, B. H. McGovern, A. L. Cox, T. M. Rice, R. Sacks-Davis, J. Bruneau, M. Morris, J. Amin, J. Schinkel, T. Applegate, L. Maher, M. Hellard, A. R. Lloyd, M. Prins, R. B. Geskus, G. J. Dore, J. Grebely and on behalf of the InC3 Study Group

    Version of Record online : 8 JAN 2015, DOI: 10.1111/jvh.12384

  17. You have free access to this content
    Poster Session 3: Cost-Effectiveness; HCV: Diagnostics, Epidemiology, and Natural History

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 889A–942A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27525

  18. You have free access to this content
    Poster Session 4: HCV: Virology, Pathogenesis, and Immunology

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1048A–1087A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27531

  19. You have free access to this content
    The recent breakthroughs in the understanding of host genomics in hepatitis C

    European Journal of Clinical Investigation

    Volume 40, Issue 10, October 2010, Pages: 950–959, Andri Rauch, Janine Rohrbach and Pierre-Yves Bochud

    Version of Record online : 19 AUG 2010, DOI: 10.1111/j.1365-2362.2010.02337.x

  20. Antivirals in Acute Hepatitis C

    Advanced Therapy for Hepatitis C

    Geoffrey W. McCaughan, John G. McHutchison, Jean-Michel Pawlotsky, Pages: 127–131, 2011

    Published Online : 3 NOV 2011, DOI: 10.1002/9781444346343.ch16